搜索筛选:
搜索耗时5.1761秒,为你在为你在102,285,761篇论文里面共找到 3 篇相符的论文内容
发布年度:
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
[会议论文] 作者：Feng Wang,De-shen Wang,Zhao-lei Zeng,Rui-hua Xu,Zhe-zhen Li,Yun-xin Lu,Zhi-qiang Wang,Long Bai,Dong-liang,
来源：第四届广州国际肿瘤学会议 年份：2015
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetuximab in the first-line treatment of...
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
[会议论文] 作者：Feng Wang,Long Bai,Zhe-zhen Li,Chao Ren,Dong-sheng Zhang,Qi Zhao,De-shen Wang,Dong-liang Chen,Yun-xin,
来源：第四届广州国际肿瘤学会议 年份：2015
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetuximab in the first-line treatment of metastatic colorectal cancer(mCRC)in Chinese...
Mutation profiling in Chinese patients with metastatic colorectal cancer and its correlation with cl
[会议论文] 作者：Feng Wang,Zhe-Zhen Li,Zi-Chen Zhang,Fang Wang,Qi Zhao,Dong-sheng Zhang,Feng-hua Wang,Zhi-qiang Wang,Hui-yan,
来源：第四届广州国际肿瘤学会议 年份：2015
An increasing number of studies reveal the significance of genetic markers in guiding target treatment and refining prognosis.This study aims to assess the mutation profile of metastatic colorectal ca...
相关搜索：
